NewslettersIntestinal Cell NewsUncategorizedProcessa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase IIA Trial for the Treatment of GastroparesisBy Justin.choi - April 8, 2022017Processa Pharmaceuticals, Inc., announced that it has enrolled its first patient in the Phase IIA clinical trial of PCS12852 in patients with moderate to severe gastroparesis.[Processa Pharmaceuticals, Inc.] 6445212 AAAAAAAA items 1 apa 0 default asc 1 173808 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Press Release